Human metapneumovirus (HMPV) can cause upper and lower respiratory disease in people of all ages, especially among young children, older adults, and people with weakened immune systems. The U.S. saw a spike in HMPV detections during the first few months of 2023. This trend is similar to the higher-than-normal case rates of respiratory syncytial virus, or RSV, and influenza in the fall of 2022 and winter of 2023, likely related to decreased population immunity after two years of wearing face masks and social distancing.

Creative Biogene is providing Human Metapneumovirus (hMPV) Real Time RT-PCR Kit (Cat# PDHS-CR018) as an efficient tool for HMPV infection. This kit contains a specific ready-to-use system for the detection of the Human Papillomavirus. The reaction is done in one step real-time RT-PCR. Fluorescence is emitted and measured by the real-time systems' optical unit during the PCR.